Drug Enforcement Administration February 2019 – Federal Register Recent Federal Regulation Documents

Bulk Manufacturer of Controlled Substances Application: Noramco, Inc.
Document Number: 2019-02883
Type: Notice
Date: 2019-02-21
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Johnson Matthey, Inc.
Document Number: 2019-02882
Type: Notice
Date: 2019-02-21
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Research Triangle Institute
Document Number: 2019-02881
Type: Notice
Date: 2019-02-21
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Stepan Company
Document Number: 2019-02878
Type: Notice
Date: 2019-02-21
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Navinta LLC
Document Number: 2019-02877
Type: Notice
Date: 2019-02-21
Agency: Drug Enforcement Administration, Department of Justice
New Single-Sheet Format for U.S. Official Order Form for Schedule I and II Controlled Substances (DEA Form 222)
Document Number: 2019-02875
Type: Proposed Rule
Date: 2019-02-21
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) is proposing to amend its regulations to implement a new single-sheet format for order forms (DEA Form 222) which are issued by DEA to DEA registrants to allow them to order schedule I and/or II controlled substances. DEA published a notice of proposed rulemaking about this new format in November 2007 but did not finalize it. Due to the passage of time and procedural considerations, DEA is reissuing another notice of proposed rulemaking. This proposal supersedes the November 2007 proposal. This proposed rule calls for allowing the continued use of the existing triplicate DEA Form 222 until a sunset date of two years after the final rule becomes effective, which would be included in the final rule. DEA also proposes minor procedural changes, including among other things, to clarify the procedure involving who can issue the power of attorney that is required for others to sign DEA Form 222.
Importer of Controlled Substances Registration
Document Number: 2019-02874
Type: Notice
Date: 2019-02-21
Agency: Drug Enforcement Administration, Department of Justice
Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of schedule I or schedule II controlled substances.
Importer of Controlled Substances Registration
Document Number: 2019-02871
Type: Notice
Date: 2019-02-21
Agency: Drug Enforcement Administration, Department of Justice
Registrants listed below has applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of schedule I or schedule II controlled substances.
Importer of Controlled Substances Registration
Document Number: 2019-02870
Type: Notice
Date: 2019-02-21
Agency: Drug Enforcement Administration, Department of Justice
The registrant listed below has applied for and has been granted registration by the Drug Enforcement Administration (DEA) as an importer of schedule II controlled substances.
Bulk Manufacturer of Controlled Substances Registration
Document Number: 2019-02869
Type: Notice
Date: 2019-02-21
Agency: Drug Enforcement Administration, Department of Justice
The registrant listed below has applied for and has been granted a registration by the Drug Enforcement Administration (DEA) as a bulk manufacturer of various classes of schedule I and II controlled substances.
Bulk Manufacturer of Controlled Substances Registration
Document Number: 2019-02868
Type: Notice
Date: 2019-02-21
Agency: Drug Enforcement Administration, Department of Justice
The registrant listed below has applied for and been granted registration by the Drug Enforcement Administration (DEA) as a bulk manufacturer of various classes of schedule II controlled substances.
Bulk Manufacturer of Controlled Substances Registration
Document Number: 2019-02867
Type: Notice
Date: 2019-02-21
Agency: Drug Enforcement Administration, Department of Justice
The registrant listed below has applied for and been granted registration by the Drug Enforcement Administration (DEA) as a bulk manufacturer of various classes of schedule I and II controlled substances.
Importer of Controlled Substances Registration
Document Number: 2019-02866
Type: Notice
Date: 2019-02-21
Agency: Drug Enforcement Administration, Department of Justice
The registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of schedule I or schedule II controlled substances.
Ajay S. Ahuja, M.D.; Decision and Order
Document Number: 2019-02865
Type: Notice
Date: 2019-02-21
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Curium US, LLC
Document Number: 2019-02876
Type: Notice
Date: 2019-02-20
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Registration
Document Number: 2019-01862
Type: Notice
Date: 2019-02-11
Agency: Drug Enforcement Administration, Department of Justice
The registrant listed below has applied for and been granted a registration by the Drug Enforcement Administration (DEA) as bulk manufacturer of a schedule I controlled substance.
Importer of Controlled Substances Application: Almac Clinical Services Incorp (ACSI)
Document Number: 2019-01861
Type: Notice
Date: 2019-02-11
Agency: Drug Enforcement Administration, Department of Justice
Robert T. Perez, M.D.; Decision and Order
Document Number: 2019-01855
Type: Notice
Date: 2019-02-11
Agency: Drug Enforcement Administration, Department of Justice
Miles J. Nelson, M.D.; Decision and Order
Document Number: 2019-01850
Type: Notice
Date: 2019-02-11
Agency: Drug Enforcement Administration, Department of Justice
Paul Surinder Singh, D.O.; Decision And Order
Document Number: 2019-01849
Type: Notice
Date: 2019-02-11
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: PerkinElmer, Inc.
Document Number: 2019-01848
Type: Notice
Date: 2019-02-11
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Stepan Company
Document Number: 2019-01847
Type: Notice
Date: 2019-02-11
Agency: Drug Enforcement Administration, Department of Justice
Kurt L. Pflieger, M.D.; Order Dismissing Order To Show Cause
Document Number: 2019-01528
Type: Notice
Date: 2019-02-07
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Registration
Document Number: 2019-01525
Type: Notice
Date: 2019-02-07
Agency: Drug Enforcement Administration, Department of Justice
The registrants listed below has applied for and has been granted registration by the Drug Enforcement Administration (DEA) as bulk manufacturer of various classes of schedule I and II controlled substances.
Importer of Controlled Substances Application: Research Triangle Institute
Document Number: 2019-01523
Type: Notice
Date: 2019-02-07
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Registration
Document Number: 2019-01521
Type: Notice
Date: 2019-02-07
Agency: Drug Enforcement Administration, Department of Justice
The registrant listed below has applied for and been granted a registration by the Drug Enforcement Administration (DEA) as an importer of schedule I and II controlled substances.
Importer of Controlled Substances Registration
Document Number: 2019-01519
Type: Notice
Date: 2019-02-07
Agency: Drug Enforcement Administration, Department of Justice
Registrants listed below have applied for and been granted registration by-the Drug Enforcement Administration (DEA) as importers of various classes of schedule I or II controlled substances.
Importer of Controlled Substances Application: Microgenics Corporation Thermo Fisher Scientific
Document Number: 2019-01513
Type: Notice
Date: 2019-02-07
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Chattem Chemicals
Document Number: 2019-01512
Type: Notice
Date: 2019-02-07
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: IsoSciences, LLC
Document Number: 2019-01510
Type: Notice
Date: 2019-02-07
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Kinetochem, LLC
Document Number: 2019-01509
Type: Notice
Date: 2019-02-07
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Johnson Matthey Pharmaceutical Materials, Inc.
Document Number: 2019-01507
Type: Notice
Date: 2019-02-07
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Registration
Document Number: 2019-01502
Type: Notice
Date: 2019-02-07
Agency: Drug Enforcement Administration, Department of Justice
The registrant listed below has applied for and been granted registration by the Drug Enforcement Administration (DEA) as a bulk manufacturer of various classes of schedule II controlled substances.
Bulk Manufacturer of Controlled Substances Registration
Document Number: 2019-01501
Type: Notice
Date: 2019-02-07
Agency: Drug Enforcement Administration, Department of Justice
Registrants listed below have applied for and been granted a registration by the Drug Enforcement Administration (DEA) as bulk manufacturers of various classes of schedule I and II controlled substances.
Control of Immediate Precursor Used in the Illicit Manufacture of Fentanyl as Schedule II Controlled Substances; Correction
Document Number: 2019-01470
Type: Rule
Date: 2019-02-07
Agency: Drug Enforcement Administration, Department of Justice
On June 29, 2010, the Drug Enforcement Administration (DEA) placed the fentanyl immediate precursor chemical ``4-anilino-N- phenethyl-4-piperidine,'' (CASRN 21409-26-7) into Schedule II of the Controlled Substances Act. It has come to DEA's attention that the drug name listed in the final rule contained a minor error and the drug name should have been ``4-anilino-N-phenethylpiperidine (ANPP).'' This document corrects that listing in the Code of Federal Regulations. Because this change is ministerial, the DEA has determined for good cause that public notice and comment is unnecessary under the Administrative Procedure Act (APA) and is implementing this change by means of a final rule without notice and comment.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.